4//SEC Filing
Lamstein Joshua R 4
Accession 0001104659-21-099626
CIK 0001772028other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 6:49 PM ET
Size
13.8 KB
Accession
0001104659-21-099626
Insider Transaction Report
Form 4
Lamstein Joshua R
DirectorChairman
Transactions
- Conversion
Convertible Notes
2021-07-31Exercise: $0.50From: 2020-04-09Exp: 2021-07-31→ W Warrant (16,963 underlying) - Other
W Warrants
2021-07-31+1,068,016→ 1,068,016 total(indirect: By LLC)Exercise: $4.00From: 2021-10-01Exp: 2026-09-30→ B Unit (1,068,016 underlying) - Other
Convertible Notes
2021-07-31Exercise: $0.50From: 2020-04-09Exp: 2021-07-31→ W Warrant (1,963 underlying) - Other
W Warrants
2021-07-31+16,963→ 31,131 totalExercise: $4.00From: 2021-10-01Exp: 2026-09-30→ B Unit (16,963 underlying)
Footnotes (6)
- [F1]Represents accrued interest on the Convertible Notes through and including July 31, 2021 (the "Maturity Date").
- [F2]Represents the total outstanding principal amount and accrued interest on the Convertible Notes through and including the Maturity Date that were converted into W Warrants on such date. No additional consideration was required in connection with such conversion.
- [F3]Represents the W Warrants issued upon conversion of the total outstanding principal amount and accrued interest on the Convertible Notes through and including the Maturity Date. No additional consideration was required in connection with such conversion.
- [F4]Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027.
- [F5]Includes 14,168 W Warrants that were previously reported on the reporting person's Form 3 filed with the SEC on December 15, 2020.
- [F6]Represents W Warrants held by SCPS/Strategic Capital Partners LLC, of which Mr. Lamstein is a co-manager. Accordingly, he is deemed to have shared voting and dispositive power over the securities held by such entity. Mr. Lamstein disclaims beneficial ownership of such securities, except to the extent of his proportionate pecuniary interest therein.
Documents
Issuer
Scopus BioPharma Inc.
CIK 0001772028
Entity typeother
Related Parties
1- filerCIK 0001665280
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 6:49 PM ET
- Size
- 13.8 KB